| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |